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ABSTRACT The integrated stress response (ISR) is a cellular response system acti-
vated upon different types of stresses, including viral infection, to restore cellular
homeostasis. However, many viruses manipulate this response for their own advan-
tage. In this study, we investigated the association between murine norovirus (MNV)
infection and the ISR and demonstrate that MNV regulates the ISR by activating and
recruiting key ISR host factors. We observed that during MNV infection, there is a
progressive increase in phosphorylated eukaryotic initiation factor 2 (p-eIF2), re-
sulting in the suppression of host translation, and yet MNV translation still pro-
gresses under these conditions. Interestingly, the shutoff of host translation also im-
pacts the translation of key signaling cytokines such as beta interferon, interleukin-6,
and tumor necrosis factor alpha. Our subsequent analyses revealed that the phos-
phorylation of eIF2 was mediated via protein kinase R (PKR), but further investiga-
tion revealed that PKR activation, phosphorylation of eIF2, and translational arrest
were uncoupled during infection. We further observed that stress granules (SGs) are
not induced during MNV infection and that MNV can restrict SG nucleation and for-
mation. We observed that MNV recruited the key SG nucleating protein G3BP1 to its
replication sites and intriguingly the silencing of G3BP1 negatively impacts MNV rep-
lication. Thus, it appears that MNV utilizes G3BP1 to enhance replication but equally
to prevent SG formation, suggesting an anti-MNV property of SGs. Overall, this study
highlights MNV manipulation of SGs, PKR, and translational control to regulate cyto-
kine translation and to promote viral replication.
IMPORTANCE Viruses hijack host machinery and regulate cellular homeostasis to ac-
tively replicate their genome, propagate, and cause disease. In retaliation, cells pos-
sess various defense mechanisms to detect, destroy, and clear infecting viruses, as
well as signal to neighboring cells to inform them of the imminent threat. In this
study, we demonstrate that the murine norovirus (MNV) infection stalls host protein
translation and the production of antiviral and proinﬂammatory cytokines. However,
virus replication and protein translation still ensue. We show that MNV further pre-
vents the formation of cytoplasmic RNA granules, called stress granules (SGs), by re-
cruiting the key host protein G3BP1 to the MNV replication complex, a recruitment
that is crucial to establishing and maintaining virus replication. Thus, MNV promotes
immune evasion of the virus by altering protein translation. Together, this evasion
strategy delays innate immune responses to MNV infection and accelerates disease
onset.
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Human noroviruses (HuNoVs) are positive sense single-stranded RNA viruses thatbelong to the Caliciviridae family. They are a major cause of acute gastroenteritis
in developing and developed countries (1–3). The onset of symptoms such as diarrhea,
nausea, vomiting, and abdominal cramps usually commences 12 to 48 h after exposure
to the virus and typically lasts no more than 48 h (4–6). Despite its signiﬁcant health
burden, there are currently no effective treatments or preventative vaccines for HuNoV
infections, even though vaccines are under development (7–11). Advances in the use of
antiviral agents to control HuNoV outbreaks have been severely delayed by the fact
that HuNoVs are difﬁcult to cultivate in the laboratory. Recent studies have shown that
HuNoV is able to replicate in B-cell like cell lines when cocultured with speciﬁc enteric
bacteria or in enteric organoids (12, 13). However, viral replication is poor with only a
2- to 3-log increase in viral titer, and thus the closely related genogroup V murine
norovirus (MNV) remains a robust tissue culture system and small animal model (14).
The MNV genome is an 7.5-kb positive-sense RNA molecule that encodes 9 or 10
proteins (depending on translation of open reading frames [ORFs] and cleavage of gene
products [15, 16]) that have roles in replication of the viral genome, polyprotein
cleavage, translation, host manipulation, and assembly of virus particles. The 5= end of
the genome is covalently attached to viral protein g (VPg or NS5) and is polyadenylated
at the 3= end. The VPg protein mediates translation of the viral genome via interaction
with host translation factors (17, 18). The remaining nonstructural proteins (ORF1)
associate with the viral replication complex (RC) in induced membrane clusters (19, 20),
as well as interacting with host factors to manipulate cellular homeostasis and promote
viral replication. Not all proteins encoded by ORF1 have been functionally character-
ized, but previous studies revealed that the MNV NS1/2 protein associates with the
endoplasmic reticulum (ER) and the host protein VAP-A (21, 22), whereas NS3 associates
with microtubules and lipid-rich bodies in the cytoplasm (23). Further, NS7 acts as the
RdRp (24, 25), and NS6 is the protease cleaving the polyprotein (26, 27).
Noroviruses cause acute and chronic infections that often involve manipulation of
host processes and innate immune responses at multiple levels (reviewed in reference
28). The presence of viral double-stranded RNA (dsRNA) and proteins during MNV
infection is recognized as foreign by the integrated stress response (ISR), and this can
activate antiviral innate immune pathways. This recognition of infection can result in a
myriad of responses, the most important being the type I and type III interferon (IFN)
responses (15); however, the exact mechanisms employed to restrict and clear noro-
virus infections are not completely deﬁned.
In the presence of cellular stressors, the ISR can be activated by eukaryotic initiation
factor 2 (eIF2) kinases such as dsRNA sensor protein kinase R (PKR), the ER-stress
sensor PKR-like endoplasmic reticulum kinase (PERK), general control nonderepressible
2 kinase (GCN2), and heme-regulated kinase (HRI). The activation of these sensors can
lead to the phosphorylation of eIF2, which relinquishes eIF2’s ability to bind to the
40S ribosomal subunit, prompting translational stalling and the aggregation of stalled
translation preinitiation complexes (29–31). Together with the Ras-GAP SH3 domain
binding protein (G3BP), T-cell restricted intracellular antigen 1 (TIA-1), and TIA-1-related
protein (TIAR), these aggregates form stress granules (SGs) to stall translation and
protect the cell from accumulating misfolded proteins during viral infections. SGs
contain the preinitiation complexes that are typically comprised of various initiation
factors, including eIF2, eIF3, eIF4, eIF4, eIF4G, and eIF5, as well as the 40S ribosomal
subunit, which ensures that SGs reactivate translation rapidly after a successful stress
recovery (32). SGs have also been shown to regulate and control cytokine mRNA
aggregation and expression.
Several viruses manipulate the ISR to avoid immune detection by inhibiting trans-
lation and preventing the formation of SGs. Sindbis virus strongly inhibits the transla-
tion of cellular mRNA in PKR-dependent, as well as PKR-independent, mechanisms (33).
Inﬂuenza A virus inhibits the phosphorylation of eIF2 and therefore prevents the
induction of stress granules (34). Poliovirus, herpes simplex virus 1, and West Nile virus
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interferes with SG formation by cleaving or sequestering SG nucleating proteins such
as G3BP and TIA-1 (35–37).
In this study, we demonstrate that MNV infection leads to the phosphorylation of
eIF2, via PKR, and the subsequent host cell translational shutoff, but this does not
affect viral translation. However, restoration of active eIF2 does not alleviate host cell
translational repression, suggesting that these events are uncoupled. Further, we show
that this translational shutoff is associated with a decrease in cytokine translation and
that MNV inhibits the formation of SGs by recruiting the SG nucleating factor G3BP1 to
the sites of virus replication, a recruitment that is essential for MNV replication. Thus, we
provide evidence that MNV manipulates the PKR–p-eIF2–SG axis to promote its own
replication but equally as an immune evasion strategy.
RESULTS
MNV infection induces eIF2 phosphorylation. During our investigations of the
intracellular replication of MNV we noticed changes in the level of host cell protein
translation. To interrogate the inﬂuence of MNV on translation, we investigated
whether MNV infection and replication induced eIF2 phosphorylation (Fig. 1A and B).
Bone marrow-derived macrophage (BMM) cells were left untreated (mock), treated with
the oxidative stressor sodium arsenite (NaAs; 250 M for 20 min), or infected with MNV
for 12 h. Our Western blot (WB) analysis of whole-cell lysates revealed that MNV
infection, similar to the NaAs positive control, induced an increase in phosphorylated
eIF2 (p-eIF2) levels, whereas the total levels of eIF2 remained constant (Fig. 1A).
To further these initial observations, we investigated the kinetics of eIF2 phos-
phorylation throughout the course of the viral infection. Thus, MNV-infected cell lysates
were collected at 3, 6, 9, and 12 h postinfection (hpi) and WB analysis was performed
with antibodies for p-eIF2, MNV NS7, and actin (Fig. 1B). Interestingly, we did not
observe a change in eIF2 phosphorylation levels at 3 hpi compared to uninfected and
untreated cells; however, as infection progressed, there was a gradual and noticeable
increase in eIF2 phosphorylation at 6, 9, and 12 hpi. This establishes that MNV
infection induces p-eIF2 as viral replication proceeds (Fig. 1B).
eIF2 phosphorylation status corresponds to a repression of host cell protein
translation during MNV infection. One of the main consequences of eIF2 phos-
phorylation is the global shutoff of host cell protein translation (38, 39). To determine
the effects of increasing eIF2 phosphorylation levels on cellular translation, BMM cells
were infected with MNV and, at the indicated times postinfection (3, 6, 9, 12, and 15
hpi), the cells were pulsed with puromycin for 20 min prior to whole-cell lysate
collection (for WB) and cell ﬁxation (for immunoﬂuorescence [IF]) (Fig. 1C and D,
respectively).
Puromycin incorporates into newly translated polypeptides and terminates the
translation of the full-length protein. Thus, newly synthesized proteins can therefore be
visualized using an anti-puromycin antibody and accurately represents translational
activity (40). Our WB analysis revealed that there was an increase in the amount of
puromycin incorporated in active protein translation up to 6 hpi (Fig. 1C). However, as
the infection progressed from 9 hpi (indicative by NS7 labeling) and the level of p-eIF2
increased, the levels of puromycin-labeled proteins were reduced (Fig. 1C). The WB
results were supported by IF analysis demonstrating that incorporation of puromycin
(Fig. 1D, green) begins to diminish in MNV-infected cells from 9 hpi, and by 12 hpi we
observed a signiﬁcant reduction in puromycin incorporation (Fig. 1D and E). Together,
these results conﬁrm that the MNV-induced increase in eIF2 phosphorylation corre-
lates with a decrease in host cell protein translation. Interestingly, MNV protein trans-
lation (as determined by NS7 expression) steadily increases over the course of the
infection even in the presence of eIF2 phosphorylation and host cell protein transla-
tion shut down (Fig. 1C).
PKR induces the phosphorylation of eIF2 during MNV infection, but transla-
tion repression is PKR independent. During viral infection, PKR and PERK are two
major kinases induced to prevent viral replication by phosphorylating eIF2 and
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inhibiting translation (41, 42). To investigate the potential role of PKR and/or PERK in
mediating phosphorylation of eIF2 during MNV infection, we utilized a PKR inhibitor
(C16), shown to suppress PKR-mediated phosphorylation of eIF2 (43), and a PERK
inhibitor (ISRIB), shown to suppress PERK-mediated phosphorylation of eIF2 (44) to
FIG 1 MNV infection phosphorylates eIF2 and shuts down host cell translation. (A) BMMs were uninfected, uninfected but
NaAs treated (250 M for 20 min), or MNV infected (MOI of 5) for 12 h. The WB was immunolabeled with anti-NS7, anti-p-eIF2,
and anti-eIF2 antibodies. Nonspeciﬁc lanes were removed to generate the image. (B) Immunoblot analysis of uninfected,
uninfected/NaAs-treated (250 M for 20 min), or MNV-infected (MOI of 5) cell lysates harvested at 3, 6, 9, and 12 hpi. The WB
was immunolabeled with anti-NS7, anti-p-eIF2 and anti-actin antibodies. (C and D) BMM cells were either infected with MNV
(MOI of 5) or left uninfected and analyzed for their translation using puromycin (10 g/ml). (C) Immunoblot analysis of
puromycin-treated (20 min) cell lysates harvested at 3, 6, 9, 12, and 15 hpi. The WB was immunolabeled with anti-puromycin,
anti-NS7, anti-p-eIF2, and anti-actin antibodies. (D) IF analysis of puromycin-treated (10 g/ml for 30 min) cells at 6, 9, and
12 h postinfection. Cells were stained with anti-puromycin, anti-NS5, and DAPI for the merged image. Asterisks indicate
uninfected cells displaying a high signal for anti-puromycin. Samples were analyzed via the Zeiss LSM 710 confocal microscope
and analyzed with ZEN software. (E) Quantiﬁcation of puromycin raw integrated density (RawIntDen) level of mock-infected
and MNV-infected cells at 6, 9, and 12 hpi. 6 hpi, mock, n 113, bystander, n 108, and MNV, n 38; 9 hpi, mock, n 125,
bystander, n 108, and MNV, n 40; 12 hpi, mock, n 260, bystander, n 148, and MNV, n 81. Means  the SEM are
shown, and an unpaired two-tailed t test was performed. ****, P  0.0001.
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treat MNV-infected RAW 264.7 cells (Fig. 2A). Cells were infected with MNV and
subsequently treated with 1 M C16 and/or 0.5 M ISRIB at 1 hpi. Cell lysates were
collected at 12 hpi, and WB analysis was performed using an anti-p-eIF2 antibody. C16
treatment of MNV-infected cells substantially decreased the levels of p-eIF2 compared
to untreated MNV-infected cells (Fig. 2B, dimethyl sulfoxide [DMSO]/C16 ratio, 1:0.54).
In contrast, we observed a slight decrease in the p-eIF2 levels in the ISRIB-treated
MNV-infected cells (Fig. 2B, DMSO/ISRIB ratio, 1:0.88). These results indicate that the
phosphorylation of eIF2 observed during MNV infection is primarily mediated via PKR
and not PERK.
Due to our observations that eIF2 phosphorylation was mediated via PKR, we
speculated that inhibition of PKR activity would restore the repression of host cell
protein translation. After MNV infection and C16 treatment, cells were incubated with
puromycin before harvesting lysates at 12 or 15 hpi. Similar to previous results, protein
translation is severely inhibited in the untreated MNV-infected cells; however, surpris-
ingly, this phenotype was also maintained even in the presence of C16 and the lack of
p-eIF2 (Fig. 2C). Thus, our results indicate that MNV-induced repression of host
translation is uncoupled and independent of a PKR and p-eIF2-mediated mechanism
and must occur via a different regulatory pathway.
The MNV NS3 protein induces host cell protein translation arrest. Previous
studies have suggested that the MNV protease NS6 can inﬂuence host cell protein
translation via cleavage of the translation accessory factor PABP (45). To verify these
observations, we expressed PABP-GFP in RAW 264.7 and infected the cells with MNV for
12 h. Neither the viral protein NS5 (VPg) nor NS6 (protease) colocalized with PABP-GFP
in infected cells, and PABP-green ﬂuorescent protein (GFP) expression was still ob-
FIG 2 Treatment with PKR inhibitor C16 abolishes phosphorylation of eIF2 but does not rescue host translation. (A) RAW 264.7 cells were either
uninfected or MNV infected (MOI of 5), treated with either DMSO, C16 (1 M), ISRIB (0.5 M), or C16ISRIB at 1 hpi for 12 h before cell lysate
samples were obtained. Lysates were analyzed via immunoblotting and immunolabeled with anti-NS7, anti-p-eIF2, or anti-actin antibodies. (B)
Quantiﬁcation of p-eIF2. Ratios: uninfected DMSO/C16 (1:0.64 0.12, P 0.015, n 5), DMSO/ISRIB (1:0.72 0.07, P 0.0013, n 3), and
DMSO/C16ISRIB (1:0.96 0.23, P 0.83, n 3); MNV-infected DMSO/C16 (0.54 0.09, P 0.0008, n 5), DMSO/ISRIB (0.88 0.06, P 0.03,
n 3, and DMSO/C16ISRIB (1:0.70 0.13, P 0.02, n 3). Statistics were calculated by using a Student t test; the means the SEM are shown.
(C) RAW 264.7 were either uninfected or MNV infected (MOI of 5) and treated with either DMSO or C16 (1 M) at 1 hpi for 12 or 15 h. At 30 min
before the cell lysate samples were obtained, the cells were treated with puromycin (10 g/ml for 30 min) and immunolabeled with anti-NS7,
anti-p-eIF2, anti-puromycin, and anti-calnexin antibodies.
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served (see Fig. S1A in the supplemental material). Further, we cotransfected cDNA
expression plasmids encoding MNV NS3, NS6, or NS7 (RdRp) with PABP-GFP in HEK
293T cells. Upon cotransfection with NS6 and NS7, the PABP-GFP expression levels
seemed unperturbed. However, cotransfecting PABP-GFP with NS3 signiﬁcantly re-
duced PABP-GFP levels compared to the control (Fig. S1B). It is important to note that
we did not detect any smaller sized protein bands for PABP-GFP that would indicate
virus-induced cleavage of this protein, even in the presence of the MNV NS6 protease
expressed during replication (Fig. S1B).
To determine which MNV proteins might affect host cell translation, we utilized
puromycin incorporation in individual ORF1 protein-transfected cells. Thus, HEK 293T
and Vero cells were transfected with plasmids encoding the single ORF1 proteins and
treated with puromycin prior to immunoblot or IF analysis. We observed no signiﬁcant
change in the amount of incorporated puromycin in cells expressing MNV NS1/2, NS4,
NS5, NS6, or NS7. Intriguingly, we observed a profound absence of puromycin incor-
poration in cells expressing the MNV NS3 protein (Fig. 3). These results suggest that the
MNV NS3 has an impact on the host protein translational efﬁciency. In contrast to
previous reports, we observed that the MNV NS6 protease did not inﬂuence host
protein translation or cleave the translation accessory factor PABP (Fig. S1).
FIG 3 Expression of MNV NS3 protein abolishes host cellular translation. (A) HEK 293T cells were
transfected with cDNA expression plasmids encoding the individual His-tagged MNV NS proteins for 18 h,
at which point the cells were pulsed with puromycin as previously described, and whole-cell lysates were
obtained and immunolabeled with anti-puromycin antibodies. (B) Densitometry analysis of puromycin
signal in MNV NS protein-transfected cells compared to mock-transfected cells (n 3, ANOVA, means the
SEM; **, P  0.01; ****, P  0.0001). (C) Vero cells were transfected with single His-tagged MNV NS proteins
and treated with puromycin before the cells were ﬁxed and permeabilized for IF. Cells were immunolabeled
with antibodies against puromycin (green), 6His (red), and DAPI. Samples were captured by using a Zeiss
LSM 710 confocal microscope and analyzed with ZEN software.
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MNV-induced suppression of host cell protein translation results in the inabil-
ity of infected cells to produce major cytokines. The innate immune response is
crucial during MNV infection; speciﬁcally, STAT1 and type I and III interferons (IFNs) play
essential roles in combatting infection (14). We were interested in investigating the
impact of impaired protein translation on the innate immune response to MNV
infection, and investigated the cytokines IFN-, tumor necrosis factor alpha (TNF-),
and interleukin-6 (IL-6) since they represent major immune response pathways. First,
we tested whether MNV infection induces the transcriptional activation of IFN-, TNF-,
and IL-6. We infected RAW 264.7 with MNV, treated them with poly(I·C), or left them
untreated for 9, 12, and 15 h. Transcription levels were assessed using reverse
transcription-quantitative PCR (RT-qPCR) and compared to mock-treated cells (Fig. 4A).
Poly(I·C) stimulation led to the robust induction of IFN-, TNF-, and IL-6 transcription,
observed through increasing mRNA levels compared to untreated cells. MNV-infected
cells also showed similar increases in mRNA levels for both IFN- and TNF- compared
to poly(I·C)-treated cells (Fig. 4Ai and ii). However, although we observed a slight
increase in IL-6 transcriptional response, this increase was much less profound
(Fig. 4Aiii).
To test whether the translation of these major cytokines is affected by the global
host translation shutoff during MNV infection, we infected RAW 264.7 cells with MNV,
treated them with poly(I·C) and the secretion inhibitor brefeldin A (BFA), or left them
untreated (Fig. 4B). Cell culture supernatant samples were harvested at 9, 12, and 15 hpi
and cytokine secretion was measured via enzyme-linked immunosorbent assay (ELISA).
Untreated cells, as well as cells stimulated with poly(I·C) but treated with BFA, secreted
no or only small amounts of IFN-, TNF-, and IL-6 at any time point tested. In contrast,
poly(I·C)-stimulated cells released large amounts of all three cytokines into the tissue
culture supernatant as early as 9 h posttreatment. Interestingly, cells infected with MNV
showed signiﬁcantly smaller amounts of IFN-, TNF-, and IL-6 being secreted into the
cell supernatant compared to poly(I·C)-treated cells (Fig. 4B). Cytokine levels observed
for MNV-infected cells were similar to poly(I·C)- and BFA-treated cells, suggesting that
secretion might be inhibited, comparable to the function of BFA. Surprisingly, general
protein secretion is not disturbed in MNV-infected macrophages (Fig. S2), indicating
that the reduction in protein levels is likely related to our observed MNV-induced
translational inhibition.
MNV infection inhibits stress granule formation. One of the control mechanisms
for translation of IFN-stimulated genes and cytokines is the sequestering of the
encoding mRNA within cytoplasmic RNA granules, e.g., SGs (46, 47). Based on our
observed profound effect of MNV infection on host cell translation and innate immune-
associated pathways, we aimed to investigate whether MNV replication also manipu-
lated the formation of SGs. Thus, BMM cells were infected with MNV for 12 h, and cells
were analyzed by IF with speciﬁc antibodies against the SG marker eIF3 and the viral
VPg protein NS5 (Fig. 5A). In uninfected control cells, SG formation was not observed
(Fig. 5A to C); however, treatment with NaAs induced the formation of numerous and
obvious round cytoplasmic puncta (Fig. 5A, g to i, arrowheads). Interestingly, cells
infected with MNV did not appear to contain SGs (Fig. 5A, d to f, arrowheads),
suggesting that MNV infection either does not induce SG formation or that the virus
inhibits the formation of SGs.
To determine whether MNV interferes with SG formation, cells were infected with
MNV for 12 h and subsequently treated with NaAs (Fig. 5A, j to l). We observed an
inhibitory effect of MNV on the amount of NaAs-induced SGs (Fig. 5A, j to l) compared
to NaAs-treated uninfected cells (Fig. 5A, g to i). In NaAs-treated and MNV-infected cells
exhibiting SG formation, the morphology of the SGs was smaller and elongated, instead
of having a typical, round appearance (Fig. 5A, j to l). To quantitate the changes
observed, we determined the number of SG foci within MNV-infected and uninfected
cells in the presence of NaAs (Fig. 5B and C). MNV-infected cells displayed a signiﬁcantly
lower number of SGs within the cell compared to uninfected cells during NaAs
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treatment. In uninfected cells, an average of four SGs per cell were observed (Fig. 5B,
blue), with only 4% of cells (9 cells) containing no SGs (Fig. 5C, blue). In contrast,
infected cells had only an average of two SGs per cell (Fig. 5B, red), and 45% of infected
cells (82 cells) contained no SGs at all (Fig. 5C, red). Intriguingly, our observations are
in contrast to those of Humoud et al., who observed that MNV infection did not impact
on arsenite-induced SG assembly (48).
Previous reports have indicated that some viruses prevent the induction of SGs by
viral protease-mediated cleavage of G3BP1 and other accessory proteins (49). To
determine whether this was also true for MNV infection, we investigated the protein
levels of eIF3, G3BP1, and TIA-1 by WB. We observed no signiﬁcant change in the total
FIG 4 MNV infection in macrophages induces cytokine transcription but inhibits their secretion. (A) RAW 264.7 cells were
either MNV infected (MOI of 5) for 9, 12, and 15 h or poly(I·C) treated. RNA samples were taken and analyzed via RT-qPCR
for the cytokines IFN- (i), TNF- (ii), and IL-6 (iii). (B) RAW 264.7 cells were mock infected, infected with MNV (MOI of 5)
for 9, 12, and 15 h, or poly(I·C) or poly(I·C)BFA treated. Cell culture supernatants were analyzed for the secretion of the
cytokines IFN- (i), TNF- (ii), and IL-6 (iii) by using ELISA (n 3, ANOVA, means  the SEM; **, P  0.01; ****, P  0.0001).
Fritzlar et al. ®
May/June 2019 Volume 10 Issue 3 e00960-19 mbio.asm.org 8
 o
n








FIG 5 MNV infection alters SG formation in sodium arsenite-treated cells without affecting key SG protein levels. (A) BMMs were mock
infected (a to c), infected with MNV (MOI of 5) for 12 h (d to f), NaAs treated (250 M for 20 min) (g to i), or MNV infected and NaAs treated
(j to l). The cells were ﬁxed for IF analysis and immunolabeled with eIF3 (green), VPg (red, indicating infection), and DAPI (blue). Samples
were captured via the Zeiss LSM 710 confocal microscope and analyzed with ZEN software. (B and C) SGs in NaAs-treated mock-infected
(218 cells) and MNV-infected (182 cells) samples were counted from two independent experiments each and collated. (B) Box-and-whiskers
plot, where the whiskers represent minimum to maximum, and the box represents the mean with error bars  the SEM. An unpaired
two-tailed t test was performed (****, P 0.0001). (C) Quantitation demonstrating the total number of cells (y axis) containing various
amount of SGs (x axis). The blue line represents the number of SGs in uninfected cells (n 218 cells), and the red line represents the number
of SGs in MNV-infected cells (n 182 cells). (D) BMM cells were either mock infected or MNV infected (MOI of 5), and whole-cell lysates
were collected at 3, 6, 9, and 12 hpi. A Western blot was immunolabeled with anti-eIF3, anti-G3BP1, anti-TIA-1, anti-NS7, and anti-actin
antibodies.
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protein levels or size of any of these proteins as infection progressed, indicating that
MNV does not manipulate SG formation through protease-mediated cleavage of key SG
proteins (Fig. 5D). These results suggest that MNV does not induce SGs even though
eIF2 is phosphorylated and has an inhibitory effect on SG induction.
MNV recruits the key SG nucleating proteins G3BP1 to the sites of virus
replication, which is critical for efﬁcient MNV replication. To examine the ability of
MNV to prevent SG induction, we visualized the distribution of two key SG nucleating
proteins, eIF3 and G3BP1, by IF analysis in MNV-infected BMM cells (Fig. 6). We
observed no signiﬁcant altered distribution of eIF3 in MNV-infected cells, either at the
sites of viral replication or to discrete cytoplasmic foci (Fig. 6A, compare i to a). In
contrast, we observed a dramatic redistribution and sequestering of G3BP1 to the sites
of MNV replication as identiﬁed with antibodies to the MNV VPg protein (NS5) (Fig. 6A,
compare j to b). The sequestering of G3BP1 also occurred in MNV-infected cells that
were additionally treated with NaAs (Fig. 6A, compare n to f). To ensure that there was
no unforeseen cross-reactivity between the anti-G3BP1and anti-VPg antibodies, we also
performed IF analysis with anti-p20 (NS4) antibodies and observed the same result
(Fig. 6B, compare h to d).
As we had observed that G3BP1 had been sequestered within the MNV RC, we
sought to determine whether this was a functional consequence for evasion of the SG
antiviral response or a requirement for replication. Intriguingly, in a recent CRISPR
screen, G3BP1 was observed as the second most critical host factor, next to the receptor
CD300lf, in facilitating MNV infection and replication (50). Since the CRISPR knockout of
G3BP1 was observed to completely inhibit infection, we utilized RNAi-mediated sup-
pression of G3BP1 to identify how MNV may require G3BP1 for replication. Thus, cells
were incubated with different RNAi’s speciﬁc for the murine G3bp1 gene, and the
suppression of G3BP1 expression was assessed by WB analysis. Small interfering RNA
(siRNA)-mediated treatment resulted in a reduction of the G3BP1 protein (Fig. 6C).
Upon subsequent infection of these cells, we observed an attenuation in MNV repli-
cation by WB (NS7) (Fig. 6C) and the production of infectious virus by plaque assays
(3.5/4-log reduction [representing an80 to 90% decrease in infectious virus]) (Fig. 6D).
To further examine the impact of G3BP1 on MNV replication, we knocked out G3BP1
expression in BV2 cells via CRISPR-Cas9 (G3BP1-KO). In G3BP1-KO BV2 cells, we rein-
troduced G3BP1 by transfecting wild- type mouse G3BP1 (WT-mG3BP1) and two
mG3BP1 protein deletion mutants: mG3BP1–ΔRGG (ΔRGG; deletion of the cooperative
RNA binding domain [RGG] from amino acids 408 to 465 [aa408-465]) and mG3BP1–
ΔRRMRGG (ΔRRMRGG; this also includes the RNA-binding domain [RRM] from aa340-
407), as well as an empty vector (Fig. 6E and F). We infected these cells with MNV and
collected virus containing tissue culture ﬂuid at 12 and 24 hpi to measure viral titers. In
WT-BV2 cells, peak virus replication (107 PFU/ml) was observed after 12 hpi, and this
level remained steady until 24 hpi (Fig. 6F, blue line). Consistent with our siRNA results,
knockout of G3BP1 resulted in the complete abolishment of virus replication, high-
lighting the importance of G3BP1 for MNV replication (Fig. 6F, green line). Interestingly,
the reintroduction of WT-mG3BP1 into mG3BP1-KO cells completely restored virus
replication to WT BV2 levels (107 PFU/ml) by 24 hpi; however, the rescue of MNV
replication was delayed by 12 h (Fig. 6F, red line). Furthermore, the removal of the
G3BP1–ΔRGG domain resulted in the partial rescue of MNV replication by 24 hpi (105
PFU/ml, 2 logs lower than WT BV2) (Fig. 6F, purple line); however, the removal of the
G3BP1–ΔRRMRGG domains resulted in a 4-log reduction of viral titers (Fig. 6F, orange
line).
We suggest, based on these observations, that the recruitment of G3BP1 to the MNV
RC is essential for virus replication. At this point we have not been able to identify at
what stage and how G3BP1contributes to MNV replication; however, we speculate that
it contributes to binding of the MNV viral RNA perhaps to stabilize some protein-RNA
interactions. It is important to note that sequestration of G3BP1 is also critical to
prevent SG formation and promote viral replication without interference of the innate
immune response.
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FIG 6 MNV recruits G3BP1 and requires G3BP1 for efﬁcient viral replication. (A) BMMs were mock infected (a to d), NaAs treated (250 M for 20
min) (e to h), infected with MNV (MOI of 5) for 12 h (i to l), or MNV infected and NaAs treated (m to p). Cells were ﬁxed for IF analysis and
immunolabeled with anti-eIF3 (magenta), anti-G3BP1 (green), VPg (red, indicating infection), and counterstained with DAPI (blue). (B) BMM cells
were mock infected (a to d) or MNV infected (MOI of 5, 12 h) (e to h). Cells were ﬁxed for IF analysis and immunolabeled with anti-G3BP1 (green)
or anti-NS4 (red) and counterstained with DAPI (blue). (A and B) Samples were captured via the Zeiss LSM 710 confocal microscope and analyzed
with ZEN software. (C and D) BMMs were untreated, siControl or siG3BP1 treated, and either mock infected or MNV infected (MOI of 5). (C)
Whole-cell lysates were collected for WB (immunolabeled with anti-NS7, anti-G3BP1, and anti-GAPDH). (D) Tissue culture ﬂuids were collected for
(Continued on next page)
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The shutdown of host cell translation is one of the major host defense mechanisms
against viral infections. Viral replication is completely dependent on host cell transla-
tion, since viruses lack their own translational machinery and parasitize the hosts.
Therefore, a reduction in host protein translation will likely lead to a decreased
translation of viral proteins and interfere with efﬁcient viral replication. Interestingly,
translation of viral proteins such as NS7, the viral polymerase, does not seem to be
affected by the reduced host protein translation during MNV infection because intra-
cellular amounts of NS7 increase from 6 hpi onward, whereas host protein translation
subsides (Fig. 1B). These observations strongly suggest that MNV employs an alterna-
tive mechanism to initiate translation, independent of cellular protein translation (51).
The HuNoV and MNV VPg proteins have been shown to interact with the translation
initiation complex through eIF4GI and eIF4E, suggesting a role of NS5 in the initiation
of viral protein translation (52, 53). Translation of MNV proteins, which is independent
of the cellular cap-dependent protein translation, could be mediated by VPg and allow
viral protein translation to occur in the absence of cellular protein translation (54). This
would be a great advantage for the virus, not only by forcing the cell to preferentially
translate viral proteins but also by diminishing the innate immune response by
preventing the translation of immune effectors such as cytokines.
To uncover how MNV manipulates the ISR, we investigated the PKR/eIF2 pathway,
which is a major regulator of the ISR (Fig. 1 to 3). We demonstrated that MNV infection
leads to the phosphorylation of eIF2, supporting the observations by Humoud et al.
(48), and as infection progresses the amount of p-eIF2 drastically increases, resulting
in timely host cell translational shutoff (Fig. 1). Even though translation was upregu-
lated early during the infection (6 hpi), there was a continuous decrease in the amount
of puromycylated proteins at later stages of the infection (from 9 hpi), indicating a
reduction in global host cell translation (Fig. 1B). Based on immunoblot and IF analyses
(Fig. 1C), MNV starts to affect host cell translation from 9 hpi, reducing host cell
translation to a minimum in most infected cells by 12 hpi (Fig. 1C). Expression studies
of single viral proteins revealed that NS3 expression alone is sufﬁcient to induce
translation inhibition (Fig. 3).
We presumed that p-eIF2 may be regulated via PKR which is activated by binding
to dsRNA produced during MNV infection. We initially showed that phosphorylation of
eIF2 was mediated via PKR rather than PERK (Fig. 2). Interestingly though, when cells
were treated with C16 and analyzed for their translation activity via puromycin treat-
ment, we did not observe an increase in host cell translation activity in MNV-infected
cells compared to infected, but untreated cells (Fig. 2B). These observations show that
the PKR-eIF2 axis is activated during MNV infection but is not solely responsible for
the host cell translation shutdown. However, the shutdown of host translation by MNV
is effective and robust (Fig. 3), and we show that it affects the translation of innate
immune response regulators such as cytokines (Fig. 4).
The release of cytokines such as IFN-, TNF-, and IL-6 during viral infections plays
a crucial role in the innate immune response against viruses. The transcription and
translation of cytokines are elevated in virus-infected cells, mostly due to the recogni-
tion of pathogen-associated molecular patterns (PAMPs), e.g., dsRNA. Cytokines are
then secreted into the extracellular space, where they can either bind to receptors on
neighboring cells or to receptors on the infected cell itself to enhance the antiviral
response (55). We and others have shown that MNV-infected cells increase the tran-
scription of cytokine (IFN-, TNF-, and IL-6) mRNAs (Fig. 4) (56, 57), indicating that
FIG 6 Legend (Continued)
plaque assay. n 3 (means  the SEM are shown, and an unpaired two-tailed t test was performed). (E) Schematic demonstrating WT-mG3BP1,
mG3BP1-ΔRGG, and mG3BP1-ΔRRMRGG protein mutant constructs. Each construct was transfected into BV2, and the expression levels were
demonstrated by WB. (F) WT-BV2 cells and BV2 -mG3BP1-KO cells were transfected with WT-mG3BP1, mG3BP1-ΔRGG, mG3BP1-ΔRRMRGG, and
an empty vector. After transfection, the cells were infected with MNV, and at 12 and 24 hpi tissue culture ﬂuids were collected for plaque assay.
n 3 (the means  the SEM are shown, and an unpaired two-tailed t test was performed).
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pattern recognition receptors (PRRs) such as MDA5 (58) have successfully detected the
viral infection and activated an antiviral response against it. Intriguingly, MNV-infected
cells do not secrete signiﬁcant levels of cytokines which would help to overcome and
contain the acute infection (Fig. 4). Our subsequent studies revealed that the small
amounts of secreted cytokines from infected cells were not due to the inhibition of
general protein secretion (Fig. S2). Instead, we observed that only very small amounts
of translated cytokines can be detected within the infected cells, further conﬁrming
that there is no secretion inhibition, which would cause the accumulation of cytokines
within the cells (Fig. 4). The difference in intracellular protein levels for TNF- compared
to the mRNA levels indicates an interference of the virus with either protein stability or
the translation of host cell proteins.
Like all viruses, MNV must modulate host responses to provide conditions suitable
for intracellular replication. To replicate successfully, MNV must also control the local-
ization of viral RNA within the host cell, since these replication by-products are highly
immunostimulatory. SG formation, which is part of the ISR, generates cytoplasmic
granules containing stalled translational machineries involved in regulating RNA tran-
script homeostasis (59). This mechanism serves as an extension of translation by
sequestering mRNA from active translation, while allowing the translation of certain
mRNAs. This translational regulation is typically induced upon exposure to cellular
stresses, including ER stress, oxidative stress, heat shock (60, 61), and viral infection (59).
Under stressed conditions, cells activate eIF2 kinases to phosphorylate eIF2, which
depletes the eIF2-GTP-tRNAMet ternary complex required to form the preinitiation
complex, resulting in stalled translation initiation (30, 31). These stalled preinitiation
complexes aggregate and form SGs; in this way, general protein translation is inhibited
(29). This host response to infection can affect cytokine translation; thus, some viruses
have devised strategies to regulate RNA granule function to selectively control RNA
translation and therefore promote their replication (reviewed in references 28 and 62).
Previous studies have shown that many different virus families modulate SG func-
tion to allow efﬁcient replication (63). Thus, as we observed eIF2a phosphorylation in
MNV-infected cells, we extended our IF analysis to examine whether SGs form during
MNV infection. We demonstrated via IF that SGs are reduced during MNV infection,
although eIF2 is phosphorylated. In fact, when cells are treated with NaAs, MNV
infection signiﬁcantly dampened SG formation and SGs that were present had atypical
morphologies and reduced SG numbers (Fig. 5A and B). These results suggest not only
that MNV infection does not induce SG formation but that MNV can also exert control
over SG formation. Intriguingly, Humoud et al. (48) did not observe these ﬁndings, and
it is difﬁcult to reconcile their ﬁndings with ours. The only difference is that they utilized
J774 macrophages in their study, potentially identifying subtle cell type differences.
We have shown that MNV recruits G3BP1 to sites of viral replication (Fig. 6A and B)
and demonstrate through siRNA-mediated knockdown and CRISPR-Cas9 depletion of
G3BP1 that it is required for efﬁcient viral replication (Fig. 6C to F). We postulate that
MNV recruits G3BP1 to sites of viral replication, where G3BP1 binds to viral RNA via the
RNA recognizing motif (RRM). G3BP1 recruitment to the assembly complex seems to
serve a dual purpose: (i) the promotion of viral replication (presumably by aiding in RNA
duplex unwinding) and (ii) the prevention of SG formation.
Based on our ﬁndings, MNV likely employs a strategy similar to picornaviruses and
alphaviruses to evade the innate immune response by inducing the inhibition of host
cell translation (64–67). During MNV infection, shutdown of host translation is inde-
pendent of the SG-PKR-eIF2 axis and PABP cleavage and seems to be regulated
through an unknown mechanism (Fig. 7, model). It will be interesting to investigate
whether MNV cleaves other components of the translation complex, or whether it
regulates the host translation shutdown through another pathway, such as miRNA or
preferred binding of viral mRNA to the translation complex. Overall, it is important to
note that the MNV NS3 protein allows the inhibition of cap-dependent host cell
translation, while inhibiting the formation of SGs by recruiting G3BP1 to the MNV RC,
which sequester stalled pretranslation complexes containing essential components of
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the translational machinery (Fig. 7, model). It is intriguing to speculate that MNV
selectively induces cap-dependent translation inhibition to enhance viral translation
and inhibit the innate immune response but needs access to the translational machin-
ery and therefore inhibits SG formation. This strategy not only increases viral replication
efﬁciency but also promotes immune evasion of the virus, which could explain the
rapid replication cycle and the delayed innate immune response to MNV infection.
MATERIALS AND METHODS
Cell lines. RAW 264.7 murine macrophages, bone marrow-derived macrophages (BMMs), and Vero
and HEK 293T cells were maintained in Dulbecco modiﬁed Eagle medium (DMEM; Gibco) supplemented
with 10% fetal calf serum (FCS; Gibco) and 1% GlutaMAX (200 mM; Gibco). BV2 cells were cultured in
DMEM with 10% FBS, 1% HEPES, and 1% GlutaMAX. All cell lines were cultivated at 37°C in a 5% CO2
incubator, as previously described (19).
MNV infection. RAW 264.7 macrophages, BMMs and BV2 cells were infected with MNV at a
multiplicity of infection (MOI) of 5, as previously described (19). Cells were rocked in a low volume of
media for 1 h at 37°C, before the cells were supplemented with additional media. Unless indicated
differently, cells were ﬁxed or lysed at 12 hpi. If supernatant was collected, the medium was centrifuged
at 10,000 g for 3 min to pellet cellular debris.
Lipofectamine 2000 DNA transfection. Seeded cells were incubated until 80% conﬂuence. First,
1 g of DNA in 50 l of Opti-MEM (Gibco) and 1.5 l of Lipofectamine 2000 (Life Technologies) in 48.5 l
of Opti-MEM were incubated at room temperature for 2 min. The DNA and Lipofectamine mixtures were
combined and incubated for a further 10 min. Meanwhile, the cells were washed with fresh cell culture
media. Next, 400 l of cell culture medium was added to each well. On the top, the DNA-Lipofectamine
mixture was added dropwise. Cells were incubated at 37°C until required. The method used here was
designed for a 24-well plate. The protocol was scaled according to the plate used.
Chemicals, plasmids, and antibodies. Sodium arsenite (Sigma-Aldrich) was added to the cells at a
concentration of 250 M for 20 min prior to ﬁxation or cell lysate collection. The PKR inhibitor C16
(Sigma-Aldrich) was added to infected cells at a concentration of 1 M at 1 hpi, and cell lysates were
collected at 12 hpi. The ISR inhibitor ISRIB (Sigma-Aldrich) was added at 1 hpi at 0.5 M. Puromycin (Life
Technologies) was added to cells at a concentration of 10 g/ml at indicated times prior to cell lysate
collection. Poly(I·C) (Sigma-Aldrich, catalog no. P1530) is a dsRNA analogue and was used as a positive
control for immune activation. Poly(I·C) was used at a concentration of 20 g/ml and added to the cell
culture medium in combination with Lipofectamine 2000. MNV ORF1 plasmids were described and used
previously (22).
Goat anti-eIF3, goat anti-G3BP1, and goat anti-TIA-1 were all purchased from Santa Cruz Biotech.
Rabbit anti-eIF2 was purchased from Invitrogen; Rabbit anti-actin from Sigma-Aldrich; Mouse anti-
FIG 7 Model. During MNV infection, viral factors such as proteins and/or RNA (blue hexagon) phos-
phorylate eIF2 (green oval) via PKR (orange rectangle), as well as stalling translation initiation by the
MNV NS3 protein. However, this translational arrest is uncoupled from the PKR–p-eIF2 axis. These
stalled preinitiation complexes typically aggregate with G3BP1 (gray oval) and form SGs (red cloud).
However, MNV viral factors sequester G3BP1 to the MNV RC (yellow circle) to promote replication. This
allows the inhibition of cap-dependent host cell translation, as well as inhibiting the formation of SGs.
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puromycin was obtained from Kerafast, Inc. Mouse anti-G3BP1, mouse anti-GAPDH, rabbit anti-His, and
rabbit anti-calnexin were obtained from Abcam, and rabbit anti-p-eIF2 (S52) and Alexa Fluor-
conjugated species-speciﬁc IgG were purchased from Life Technologies. Rabbit anti-NS7 and rabbit
anti-NS5 were manufactured and produced by Invitrogen.
Plaque assay. A total of 3.0 105 RAW 264.7 or BV2 cells were seeded onto 12-well plates and
incubated 37°C until 70% conﬂuent. Virus-containing supernatants were 10-fold serially diluted in DMEM,
added to plates, and rocked every 10 min for 1 h at 37°C. After incubation, a plaque assay overlay (70%
DMEM, 2.5% [vol/vol] FCS, 13.3 mM NaHCO3, 22.4 mM HEPES, 200 mM GlutaMAX, and 0.35% [wt/vol]
low-melting-point agarose) was added to each well. The overlay was solidiﬁed at 4°C for 15 min, followed
by incubation at 37°C for 48 h. The cells were ﬁxed in 10% formalin for 1 h at room temperature. The
plaque assay overlay was removed, and the cells were stained with 1 ml of toluidine blue for 30 min. The
stain was removed, the samples were rinsed with water, and plaque formations were enumerated.
Immunoﬂuorescence microscopy. Cells were rinsed twice with phosphate-buffered saline (PBS) and
ﬁxed using 4% (vol/vol) paraformaldehyde/PBS for 15 min at room temperature. The ﬁxative was
removed, and the cells were permeabilized with 0.1% (vol/vol) Triton X-100 for 10 min at room
temperature. The cells were rinsed twice with PBS and quenched with 0.2 M glycine for 10 min at room
temperature. The cells were then rinsed with PBS, and coverslips were incubated in primary antibodies
diluted in 25 l of 1% bovine serum albumin (BSA)/PBS for 1 h at room temperature. After incubation
with primary antibodies, the cells were washed three times with 0.1% BSA/PBS. Coverslips were
incubated in secondary antibodies diluted in 25 l of 1% BSA/PBS for 45 min at room temperature. The
cells were washed twice with PBS and incubated for 5 min with DAPI (4=,6=-diamidino-2-phenylindole at
0.33 g/ml in PBS. The coverslips were rinsed twice with PBS and Milli-Q water and mounted on cover
slides with ProLong Diamond (Life Technologies). The cells were analyzed using a Zeiss LSM710 confocal
microscope.
Western blot analysis. Cells were lysed with NP-40 lysis buffer containing protease inhibitor cocktail
and phosphatase inhibits. Samples were separated on a bis/tris polyacrylamide gel and transferred to a
polyvinylidene diﬂuoride membrane. The membrane was blocked with 5% BSA/PBS-T (PBS plus Tween)
for 2 h. Primary antibodies were added in 5% BSA/PBS-T and incubated overnight at 4°C. The following
day, the membrane was washed three times with PBS-T and incubated with secondary antibody in PBS-T
for 90 min at room temperature (using the Invitrogen antibodies Dk Anti-Ms AF488 [catalog no. A21202],
Dk Anti-Rb AF594 [catalog no. A21207], and Dk Anti-Ms AF647 [catalog no. A21447]). The membrane was
then washed four times in PBS-T and visualized using the MF-ChemiBIS DNR (Bio-imaging Systems).
ELISA. Cell culture supernatants were analyzed for their cytokine concentrations using mouse-
speciﬁc ELISA kits for the following cytokines: IFN- (Legend Max; BioLegend) and TNF- (ELISAkit).
Tissue culture supernatants and standards were applied to the 96-well precoated assay plate and
incubated for 2 h. Wells were washed four times in assay wash buffer before adding assay-speciﬁc
biotin-labeled detection antibody. Plates were incubated for 2 h at room temperature, and the wells were
washed four more times with assay wash buffer. A streptavidin-conjugated horseradish peroxidase was
then added, followed by incubation for a further 45 min. The plates were washed thoroughly six times
with wash buffer, and TMB substrate was added. Plates were checked every 3 to 5 min to observe the
color change. The reaction was stopped with assay stop solution. The absorbances at 450 and 570 nm
(background) were measured using a CLARIOstar microplate. Cytokine concentrations were calculated
using the ELISAanalysis.com website.
qRT-PCR. Cells for RNA extraction were lysed with TRIzol (Life Technologies). The total RNA was
isolated by phenol-chloroform extraction and then stored at –80°C. The total RNA concentration was
quantiﬁed using a NanoDrop apparatus, and 1 g of total RNA was treated with RQ1 DNase (Promega)
at 37°C for 45 min. cDNA was generated by reverse transcription using Sensifast RT (Bioline) at 25°C for
10 min, 42°C for 15 min, and 85°C for 5 min. cDNA levels were quantiﬁed by qPCR with SYBR GreenER
(Bio-Rad) under the following cycling conditions: 50°C for 8 min, 95°C for 2 min, 40 cycles of 15 s at 95°C,
and 1 min of annealing/extension at 60°C, followed by a ﬁnal extension for 10 min. The fold induction
of RNA was compared to the housekeeping gene (GADPH), and error bars indicate means the standard
errors of the mean (SEM) from triplicate experiments.
RNAi-mediated depletion of G3BP1. BMM cells were reverse transfected with 0.25 M siRNA
(Bioneer) and RNAiMAX (Invitrogen) in Opti-MEM (Gibco). Cells were incubated at 37°C and 5% CO2 for
24 h. The following day, the cells were once again transfected with 0.5 M siRNA. At 24 h posttransfec-
tion, the cells were infected with MNV at an MOI of 5 for 1 h, transfected with 0.5 M siRNA, and
incubated for a further 12 h. At 12 h postinfection, whole-cell lysates and supernatants were collected for
WB and plaque assay, respectively.
Generation of G3BP1 KO cells via CRISPR-Cas9. BV2 cells were cultured in DMEM containing 10%
FBS and 1% HEPES. BV2 cells were transiently transfected with Cas9 and a sgRNA (5=-TTCCCCGGCCCC
GGCTGATGNGG-3=) targeting exon 7 of G3BP1. BV2 cells were then single cell cloned, and G3BP1 was
sequenced using Illumina HiSeq. BV2 cells are polyploid at the G3BP1 locus, as described previously
(PMID 27540007). Clone 1A3 had four independent deletions at the sgRNA binding site resulting in two
unique 1-bp deletions, in addition to 4- and 10-bp deletions. The mutations introduced resulted in
frameshifts and the absence of detectable G3BP1 protein, as measured by WB. Sequences are available
upon request.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00960-19.
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TEXT S1, DOCX ﬁle, 0.02 MB.
FIG S1, TIF ﬁle, 1 MB.
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